Consensus Organigram Global Inc.

Stocks

OGI

CA68617J1003

Healthcare Facilities & Services

Delayed Toronto S.E. Other stock markets 20:42:21 11/06/2026 +04			5-day change	1st Jan Change
1.490 ^CAD	+0.68%		-1.32%	-35.50%

05-12	Organigram Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI
05-12	Organigram Global Inc. Updates Revenue Guidance for the Fiscal Year 2026	CI

Evolution of the Average Target: Organigram Global Inc.

Evolution of the Target Price: Organigram Global Inc.

Changes in Analyst Recommendations: Organigram Global Inc.

474efeda2dfa7001428b00.FQqHZ4r8SRgDRrFn4kxVZj7vI8BSWlKCfAXS3wOm9OA.Yl3rD8uxClpEFfcVrCFkLGuJU4UxGTXpLm20k2HuhaxwUsMT4LA-bzsu3g~a051a3625e987c21fbac5f88bf8aea66

Analysts' recommendations: Organigram Global Inc.

03-23	Organigram Says Proxy Firm ISS Recommends Approval of Sanity Group Acquisition	MT
03-23	Organigram Brief: Announced Independent Proxy Advisory Firm ISS Recommends OGI Shareholders Vote FOR Acquisition of Sanity Group GmbH	MT
21/10/25	Organigram Brief: Announcing Update to CEO Succession Plan	MT
15/04/24	Alliance Global Upgrades OrganiGram Holdings to Buy From Neutral	MT
17/07/23	Organigram Holdings Maintained at Buy at Stifel GMP Following Q2 Results; Price Target Raised to C$4.00	MT
13/04/23	Organigram Holdings Maintained at Buy at Stifel GMP After Mixed Fiscal Q2 Results; Price Target Lowered to C$1.25	MT
13/01/23	Organigram Holdings Raised to Buy at Stifel GMP Following Improved FQ1 Results; Price Target Kept at C$1.50	MT
29/11/22	Organigram Holdings Maintained at Hold at Stifel GMP Following FQ4 Results; Price Target Kept at C$1.50	MT
15/07/22	Organigram Holdings Hold Rating Maintained by Stifel GMP Following Fiscal Third-Quarter Results	MT
13/04/22	Organigram Holdings Shares Rise 4%, Upgraded to Outperform at ATB Capital	MT
12/01/22	Canaccord Genuity Upgrades OrganiGram Holdings to Speculative Buy from Hold, Adjusts Price Target to CA$3.25 from CA$3	MT
12/01/22	Organigram Holdings Price Target Raised to $3 at ATB Capital	MT
15/07/21	ORGANIGRAM : Stifel Nicolaus Adjusts OrganiGram Holdings PT to C$3.75 From C$4, Maintains Hold Rating	MT
14/07/21	ORGANIGRAM : CIBC Adjusts OrganiGram Holdings PT to C$4 From C$3.75, Maintains Neutral Rating	MT
11/06/21	ORGANIGRAM : CIBC Adjusts OrganiGram Holdings PT to C$3.75 From C$3.25, Maintains Neutral Rating	MT
11/05/21	ORGANIGRAM : CIBC Upgrades OrganiGram Holdings to Neutral from Underperform, Keeps C$3.25 Price Target	MT
15/04/21	ORGANIGRAM : Stifel Nicolaus Adjusts OrganiGram Holdings PT to C$4 From C$6, Maintains Hold Rating	MT
14/04/21	ORGANIGRAM : Raymond James Adjusts OrganiGram Holdings PT to C$5 From C$6, Maintains Outperform Rating	MT
14/04/21	ORGANIGRAM : Declines 7% As CIBC Downgrades Stock After Weak Q2 Results	MT
14/04/21	ORGANIGRAM : CIBC Downgrades OrganiGram Holdings to Underperform from Neutral, Adjusts PT to C$3.25 from C$5	MT
08/04/21	ORGANIGRAM : BMO Capital Upgrades OrganiGram Holdings to Market Perform from Underperform, Sets C$4 Price Target	MT
12/03/21	ORGANIGRAM : Raymond James Adjusts OrganiGram Holdings PT to C$6 From C$3, Maintains Outperform Rating	MT
11/03/21	ORGANIGRAM : Alliance Global Partners Adjusts OrganiGram Holdings PT to C$4 From C$2.25, Maintains Neutral Rating	MT
10/03/21	ORGANIGRAM : BMO Capital Downgrades OrganiGram Holdings to Underperform From Market Perform	MT
13/01/21	ORGANIGRAM : Raymond James Upgrades OrganiGram Holdings to Outperform From Market Perform; Price Target is C$3	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ORGANIGRAM GLOBAL INC.					+101.35%
	CANNARA BIOTECH INC.					+92.02%
	ASCEND WELLNESS HOLDINGS, INC.					+327.27%
	JUSHI HOLDINGS INC.					+202.91%
	Average					+180.89%
	Weighted average by Cap.					+172.86%